Healthcare System and Delivery Network 2010 Yearbook


#3201

187pages

GBI Research

$ 3500

In Stock


GBI Research’s new report, “Healthcare System and Delivery Network - 2010 Yearbook” provides key data, information and analysis on the Healthcare Delivery in both developed and emerging economies. The report provides market landscape, competitive landscape and market trends information on Healthcare Delivery in the US, Japan, France, Italy, Germany, Spain, the UK India, China and Brazil. 

The report provides comprehensive information on the key trends affecting healthcare delivery, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes:

  • Overall national healthcare expenditure, expenditure by category and public versus private spending.
  • The next section gives a detailed account of the healthcare infrastructure, including the healthcare providers, hospitals bed size and healthcare professionals.
  • The following section gives details on the healthcare system, health insurance providers, regulation and sources of funding impacting the healthcare system and delivery network in the US, Japan, France, Italy, Germany, Spain, the UK India, China and Brazil.
  • This is followed by profiles of key market players in the US, Japan, France, Italy, Germany, Spain, the UK India, China and Brazil.
  • The sixth section gives details on the socio-economic and demographic trends affecting the healthcare sector. It also gives information on the leading causes of death in the US, Japan, France, Italy, Germany, Spain, the UK India, China and Brazil.
  • The last section of this chapter discusses the key healthcare delivery opportunities and challenges in the US, Japan, France, Italy, Germany, Spain, the UK India, China and Brazil.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

  • Develop business strategies by understanding the trends and developments that are driving the Healthcare Delivery in both developed and emerging countries.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities.
  • What’s the next being thing in the Healthcare Delivery in the Developed and the Emerging Countries? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the Healthcare Delivery in the Developed and the Emerging Countries and the factors shaping it.
Table of Contents

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Healthcare System and Delivery Network: Introduction
2.1 GBI Research Guidance

3 Healthcare Delivery System in the US
3.1 Introduction
3.2 Healthcare Expenditure
3.2.1 Healthcare Expenditure as a Share of GDP
3.2.2 Healthcare Expenditure by Category
3.2.3 Health Care Expenditure per Capita by Source of Funding
3.3 Healthcare Infrastructure
3.3.1 Healthcare Providers
3.3.2 Hospital Beds
3.3.3 Healthcare Professionals
3.4 Healthcare System
3.4.1 Health Insurance Providers
3.4.2 Healthcare Regulation
3.4.3 Sources of Funding
3.5 Key Players in the Healthcare Industry
3.5.1 Mayo Clinic
3.5.2 Johns Hopkins Hospital
3.5.3 Cleveland Clinic
3.6 Socio-Economic and Demographic Trends Affecting Healthcare Sector
3.6.1 High Population Growth
3.6.2 Disease Profile
3.7 The US Healthcare Delivery Opportunities
3.7.1 Health Information Technology (HIT) Will Make Healthcare Delivery Safer, More Effective and More Efficient
3.7.2 Rapid Uptake of Generic Drugs Will Reduce Prescription Drug Spending
3.8 The US Healthcare Delivery Challenges
3.8.1 High Cost of Prescription Drugs Encourages Patients to Forgo Treatment
3.8.2 Decreasing Employment-based Health Insurance Coverage Increases the Number of Uninsured

4 Healthcare Delivery System in Japan

4.1 Introduction
4.2 Healthcare Expenditure
4.2.1 Healthcare Expenditure as a Share of GDP
4.2.2 Healthcare Expenditure by Category
4.2.3 Health Care Expenditure per Capita by Source of Funding
4.3 Healthcare Infrastructure
4.3.1 Healthcare Providers
4.3.2 Hospital Beds
4.3.3 Healthcare Professionals
4.4 Healthcare System
4.4.1 Health Insurance Providers
4.4.2 Healthcare Regulation
4.4.3 Sources of Funding
4.5 Key Players in the Healthcare Industry
4.6 Socio-Economic and Demographic Trends Affecting Healthcare Sector
4.6.1 High Population Growth
4.6.2 Disease Profile
4.7 Healthcare Delivery Opportunities
4.7.1 The Japanese Government Is Promoting HIT Adoption in Medical Institutions
4.7.2 Rapidly Aging Population Will Drive the Healthcare Market
4.8 Healthcare Delivery Challenges
4.8.1 Attention on Late-stage Diseases Rather Than Early Health
4.8.2 Japan Has Abundance of Hospital Beds but Understaffed Hospitals

5 Healthcare Delivery System in France
5.1 Introduction
5.2 Healthcare Expenditure
5.2.1 Healthcare Expenditure as a Share of GDP
5.2.2 Healthcare Expenditure by Category
5.2.3 Healthcare Expenditure per Capita by Source of Funding
5.3 Healthcare Infrastructure
5.3.1 Healthcare Providers
5.3.2 Hospital Beds
5.3.3 Healthcare Professionals
5.4 Healthcare System
5.4.1 Health Insurance Providers
5.4.2 Healthcare Regulation
5.4.3 Sources of Funding
5.5 Key Players in the Healthcare Industry
5.5.1 CHU de Toulouse
5.5.2 CHU de Bordeaux (Bordeaux University Hospital)
5.6 Socio-Economic and Demographic Trends Affecting Healthcare Sector
5.6.1 High Population Growth
5.6.2 Disease Profile
5.7 Healthcare Delivery Opportunities
5.7.1 Government Funding and Initiatives will Revive the Healthcare IT Market
5.7.2 The Research and Development Sector Is Mature and Growing Quickly
5.8 Healthcare Delivery Challenges
5.8.1 High Rate of Premature Alcohol-Attributable Male Mortality
5.8.2 High Unemployment Rate May Raise Tax Contributions

6 Healthcare Delivery System in Italy
6.1 Introduction
6.2 Healthcare Expenditure
6.2.1 Healthcare Expenditure as a Share of GDP
6.2.2 Healthcare Expenditure per Capita by Source of Funding
6.3 Healthcare Infrastructure
6.3.1 Healthcare Providers
6.3.2 Hospital Beds
6.3.3 Healthcare Professionals
6.4 Healthcare System
6.4.1 Health Insurance Providers
6.4.2 Healthcare Regulation
6.4.3 Sources of Funding
6.5 Key Players in the Healthcare Industry
6.5.1 Centro Diagnostico Italiano (CDI)
6.5.2 Istituto Europeo di Oncologia (IEO)
6.6 Socio-Economic and Demographic Trends Affecting Healthcare Sector
6.6.1 High Population Growth
6.6.2 Disease Profile
6.7 Healthcare Delivery Opportunities
6.7.1 Home Healthcare Devices May Pose New Ways of Delivering Care
6.7.2 Significant Demand for Medical Equipment Provides Opportunity for Growth
6.8 Healthcare Delivery Challenges
6.8.1 Significant Health Inequality among Regions Due to a Decentralized Healthcare System
6.8.2 Wide Discrepancies in Public and Private Health Providers

7 Healthcare Delivery System in Germany
7.1 Introduction
7.2 Healthcare Expenditure
7.2.1 Healthcare Expenditure as a Share of GDP
7.2.2 Healthcare Expenditure by Category
7.2.3 Healthcare Expenditure per Capita by Source of Funding
7.3 Healthcare Infrastructure
7.3.1 Healthcare Providers
7.3.2 Hospital Beds
7.3.3 Healthcare Professionals
7.4 Healthcare System
7.4.1 Health Insurance Providers
7.4.2 Healthcare Regulation
7.4.3 Sources of Funding
7.5 Key Players in the Healthcare Industry
7.5.1 DRK Kliniken Berlin (DRK Clinics Berlin)
7.5.2 Stadtisches Klinikum Gorlitz gGmbH (Municipal Hospital Gorlitz gGmbH)
7.6 Socio-Economic and Demographic Trends Affecting Healthcare Sector
7.6.1 High Population Growth
7.6.2 Disease Profile
7.7 Healthcare Delivery Opportunities
7.7.1 The Chemical and Pharmaceutical Industry in Germany Is Highly Innovative
7.7.2 Home Healthcare Likely to Provide Cost-effective and Efficient Delivery of Healthcare
7.8 Healthcare Delivery Challenges
7.8.1 Pharmaceutical Drug Costs in Germany Are Among the Most Expensive In the World
7.8.2 Unhealthy Dietary Habits and Increasing Elderly Population Increases Risk of Chronic Diseases

8 Healthcare Delivery System in Spain
8.1 Introduction
8.2 Healthcare Expenditure
8.2.1 Healthcare Expenditure as a Share of GDP
8.2.2 Healthcare Expenditure by Category
8.2.3 Healthcare Expenditure per Capita by Source of Funding
8.3 Healthcare Infrastructure
8.3.1 Healthcare Providers
8.3.2 Hospital Beds
8.3.3 Healthcare Professionals
8.4 Healthcare System
8.4.1 Health Insurance Providers
8.4.2 Healthcare Regulation
8.4.3 Sources of Funding
8.5 Key Players in the Healthcare Industry
8.5.1 The Hospital La Paz
8.5.2 Hospital de Torrevieja
8.6 Socio-Economic and Demographic Trends Affecting Healthcare Sector
8.6.1 High Population Growth
8.6.2 Disease Profile
8.7 Healthcare Delivery Opportunities
8.7.1 EMRs Will Help Deliver Healthcare Better through a Unified Database Created by the Autonomous Communities
8.7.2 Increase In Diabetes Prevalence Will Drive the Diabetes Care Devices Market
8.8 Healthcare Delivery Challenges
8.8.1 Healthcare Delivery Varies Due to a Decentralized Healthcare System
8.8.2 Immigrants Compete With Local People for Health Services

9 Healthcare Delivery System in the UK

9.1 Introduction
9.2 Healthcare Expenditure
9.2.1 Healthcare Expenditure as a Share of GDP
9.2.2 Healthcare expenditure per Capita by Source of Funding
9.3 Healthcare Infrastructure
9.3.1 Healthcare Providers
9.3.2 Hospital Beds
9.3.3 Healthcare Professionals
9.4 Healthcare System
9.4.1 Health Insurance Providers
9.4.2 Healthcare Regulation
9.4.3 Sources of Funding
9.5 Key Players in the Healthcare Industry
9.5.1 Royal National Orthopaedic Hospital NHS Trust (RNOH)
9.5.2 Royal Brompton & Harefield NHS Trust
9.6 Socio-Economic and Demographic Trends Affecting Healthcare Sector
9.6.1 High Population Growth
9.6.2 Disease Profile
9.7 Healthcare Delivery Opportunities
9.7.1 NHS Connecting for Health will provide secure and audited access to patient’s medical records
9.7.2 DH Proposal Will Drive Generic Drugs Market
9.7.3 NHS Plans to Outsource Health Services to Private Health Firms
9.8 Healthcare Delivery Challenges
9.8.1 Rising Healthcare Costs Encourage Thousands to Travel Abroad For Treatment
9.8.2 Uneven Prescription Costs across the UK

10 Healthcare Delivery System in India

10.1 Introduction
10.2 Healthcare Expenditure
10.3 Healthcare Infrastructure
10.3.1 Public Healthcare Infrastructure
10.3.2 Private Healthcare infrastructure
10.4 Healthcare Regulation
10.4.1 The Union Ministry of Health and Family Welfare (MoHFW)
10.4.2 National Programs and Schemes
10.4.3 Highlights of Budget 2010-2011
10.4.4 Health Insurance Regulation
10.5 Key Players in the Healthcare Industry
10.5.1 Apollo Hospitals Enterprise Ltd.
10.5.2 Fortis Healthcare
10.5.3 Manipal Health Systems
10.5.4 Max Healthcare
10.5.5 Narayana Hrudayalaya
10.5.6 Columbia Asia
10.5.7 Profiles of New Entrants
10.6 Sources of Funding
10.6.1 Foreign Direct Investment (FDI) & other Foreign Investments
10.6.2 Private Equity and Venture Capital
10.7 Evolving Trends in the Healthcare System in India
10.7.1 Health Cities
10.7.2 Hospotels
10.7.3 Health and Wellness
10.8 Socio-Economic and Demographic Trends Affecting Healthcare Sector
10.8.1 High Population and Economic Growth
10.8.2 Emergence of the Middle Class
10.8.3 Shift in Disease profile
10.9 Reimbursement Scenario
10.9.1 Private Health Insurance
10.10 India Healthcare Delivery Opportunities
10.10.1 Medical Tourism
10.10.2 Investments in Healthcare Infrastructure
10.10.3 Increase in Foreign Direct Investment (FDI)
10.10.4 Telemedicine
10.10.5 Opportunities in Medical Equipments Industry
10.10.6 Health Insurance
10.11 India Healthcare Delivery Challenges
10.11.1 Financial Disparity
10.11.2 Weak Infrastructure
10.11.3 Intellectual Property (IP) Concerns

11 Healthcare Delivery System in China
11.1 Introduction
11.2 Healthcare Expenditure
11.3 Healthcare Infrastructure
11.3.1 Public and Private Sector Scenario
11.3.2 Impact of Healthcare Reforms, 2009
11.4 Healthcare Regulation
11.4.1 Ministry of Health
11.4.2 The National Development and Reform Commission (NDRC)
11.4.3 Chinese Center for Disease Control and Prevention (China CDC)
11.4.4 The Ministry of Finance (MoF)
11.4.5 Ministry of Labor and Social Security (MoLSS)
11.5 Profiles of Key Players
11.5.1 United Family Hospitals Group (UFH)
11.5.2 Parkway Health, China
11.5.3 Sunnylife Global, Inc.
11.5.4 Sino-German Friendship Hospital
11.5.5 SK Group
11.5.6 Shanghai East International Medical Center
11.5.7 Global Doctor
11.6 Sources of Funding
11.6.1 Private, Share holdings and Sino-foreign Joint Venture Hospitals
11.7 Evolving Trends in the Healthcare System in China
11.7.1 Increase in Taiwanese Investment in Hospitals in China
11.7.2 Hospital Advertising
11.8 Socio-Economic and Demographic Trends Affecting the Healthcare Sector
11.8.1 Shift in Demographics
11.8.2 Rise in Personal Disposable Income
11.8.3 Rise in Lifestyle Diseases
11.9 Reimbursement Scenario
11.10 China Healthcare Delivery Opportunities
11.10.1 High growth in Medical Equipment Market
11.10.2 Growth in Pharmaceutical Industry Sector
11.10.3 Booming Healthcare Construction Market
11.10.4 Opportunity in Hospital Information Systems Sector
11.11 China Healthcare Delivery Challenges
11.11.1 Regulatory and Bureaucratic issues
11.11.2 Weak Intellectual Property Protection
11.11.3 High Cost of Prescription Drugs
11.11.4 Financial Disparity and Coverage Problems
11.11.5 Inadequate Infrastructure and Qualified Workforce
11.11.6 Language Barrier

12 Healthcare Delivery System in Brazil
12.1 Introduction
12.2 Healthcare Expenditure
12.3 Healthcare Infrastructure
12.3.1 Public and Private Sector Scenario
12.4 Healthcare Regulation
12.4.1 Unified Health System (UHS also called as SUS in Brazil)
12.4.2 National Agency of Sanitary Surveillance (ANVISA)
12.4.3 National Private Healthcare Insurance Agency (ANS)
12.5 Profiles of Key Players
12.5.1 Rede D’Or (D’Or’ or ‘The Company’)
12.5.2 Sao Luiz
12.5.3 HCor - Hospital do Coracao
12.5.4 Samaritan Hospital of Sao Paulo
12.5.5 Sociedade Beneficente Israelita Brasileira Albert Einstein (SBIBAE)
12.6 Sources of Funding
12.6.1 Joint, Foreign Direct Investment (FDI) and Private Ventures
12.6.2 Impact of Soccer World Cup 2014 and Olympic Games 2016 in Brazil
12.7 Evolving Trends in the Healthcare System in Brazil
12.7.1 Hospotels
12.7.2 Cosmetic Travel
12.8 Socio-Economic and Demographic Trends Affecting Healthcare Sector
12.8.1 Changing Population Trends
12.8.2 Impact of Financial Disparity on Disease Profile
12.8.3 AIDS Pandemic
12.9 Reimbursement Scenario
12.10 Brazil Healthcare Delivery Opportunities
12.10.1 Huge Generic Drugs Market
12.10.2 Soaring Imports of Medical Equipment
12.10.3 Growth in Pharmaceutical Sector
12.10.4 Home Healthcare Delivery Market
12.10.5 Government - The Largest Buyer of Pharmaceutical Products and Services
12.10.6 Investment Opportunities in Hospital Information Systems Sector
12.10.7 Telemedicine
12.11 Brazil Healthcare Delivery Challenges
12.11.1 High Taxes
12.11.2 Weak Intellectual Property Protection
12.11.3 Weak Infrastructure

13 Healthcare System and Delivery Network: Appendix

13.1 Market Definitions
13.2 Abbreviations
13.3 Research Methodology
13.3.1 Secondary Research
13.3.2 Primary Research
13.3.3 Models
13.3.4 Forecasts
13.3.5 Expert Panels
13.4 Contact Us
13.5 Disclaimer
13.6 Sources

Table 1: National Healthcare Expenditure, the US (% of GDP), 2000-2009
Table 2: National Healthcare Expenditure, by Category, the US ($bn), 2008
Table 3: National Healthcare Expenditure, per Capita by Source of Funding, the US ($), 2008
Table 4: National Healthcare Expenditure, by Payer, the US (%), 2008
Table 5: Healthcare Providers, the US, 2008
Table 6: Community Hospitals by Bed Distribution, the US, 2006-2008
Table 7: Healthcare Professionals, the US, 2008
Table 8: Health Insurance Coverage, the US (% of Population), 2007-2009
Table 9: Composition of the HHS Budget, the US ($m), 2010-2011
Table 10: Population Age Structure, the US (million), 2000-2020
Table 11: Health Indicators, the US, 2010
Table 12: Leading Causes of Death, by Therapeutic Area, the US, 2007
Table 13: National Healthcare Expenditure, Japan (% of GDP), 2000-2007
Table 14: National Healthcare Expenditure, by Category, Japan ($bn), 2006
Table 15: National Healthcare Expenditure, Per Capita by Source of Funding, Japan ($), 2007
Table 16: Healthcare Providers, Japan, 2008
Table 17: Hospitals, by Bed Distribution, Japan, 2007-2008
Table 18: Healthcare Professionals, by Profession, Japan, 2008
Table 19: Health Insurance Coverage, Japan (million), 2008
Table 20: Population Age Structure, Japan (million), 2000-2020
Table 21: Health Indicators, Japan, 2010
Table 22: Leading Causes of Death, by Therapeutic Area, Japan, 2009
Table 23: Leading Cause of Death, Rate Per 100,000 Population, Japan, 2000-2009
Table 24: National Healthcare Expenditure, France (% of GDP), 2000-2008
Table 25: National Healthcare Expenditure, by Category, France (%), 2008
Table 26: National Healthcare Expenditure, Per Capita by Source of Funding, France ($), 2008
Table 27: Healthcare Providers, France, 2009
Table 28: Population Age Structure, France (million), 2000-2020
Table 29: Health Indicators, France, 2010
Table 30: Leading Causes of Death, by Therapeutic Area, France, 2005
Table 31: National Health Expenditure, Italy (% of GDP), 2000-2009
Table 32: National Health Expenditure, Per Capita by Source of Funding, Italy ($), 2008
Table 33: Hospitals, Distribution by Type, Italy, 2005
Table 34: Population Age Structure, Italy (million), 2000-2020
Table 35: Health Indicators, Italy, 2010
Table 36: Leading Causes of Death, by Therapeutic Area, Italy, 2002
Table 37: National Healthcare Expenditure, Germany (% of GDP), 2000-2008
Table 38: National Healthcare Expenditure, by Category, Germany (%), 2008
Table 39: National Healthcare Expenditure, Per Capita by Source of Funding, Germany ($), 2008
Table 40: Population Age Structure, Germany (million), 2000-2020
Table 41: Health Indicators, Germany, 2010
Table 42: Leading Causes of Death, by Therapeutic Area, Germany, 2005
Table 43: National Healthcare Expenditure, Spain (% of GDP), 2000-2008
Table 44: National Healthcare Expenditure, by Category, Spain (%), 2008
Table 45: National Healthcare Expenditure, Per Capita by Source of Funding, Spain ($), 2008
Table 46: Hospitals, by Bed Distribution, Spain, 2008
Table 47: Population Age Structure, Spain (million), 2000-2020
Table 48: Health Indicators, Spain, 2010
Table 49: Leading Causes of Death, by Therapeutic Area, Spain, 2007
Table 50: Leading Causes of Death, by Age, Spain (%), 2007
Table 51: National Health Expenditure, the UK (% of GDP), 2000-2008
Table 52: Health Care Expenditure, Per Capita by Source of Funding, the UK ($), 2008
Table 53: Population Age Structure, the UK (million), 2000-2020
Table 54: Health Indicators, the UK, 2010
Table 55: Leading Causes of Death, by Therapeutic Area, the UK, 2005
Table 56: Cost Comparison of Surgeries, the UK and India ($), 2009
Table 57: Healthcare Professionals, India, 2009
Table 58: Healthcare Infrastructure, Public and Private Distribution, India (%), 2009
Table 59: Snapshot of International Finance Corporation (IFC), Investments ($m), India, (1997 - 2009)
Table 60: Prominent Health City Projects, India, 2010
Table 61: Population Age Structure, India (million), 2000 - 2020
Table 62: Health Indicators, India, 2010
Table 63: Medical Tourism Revenue, India ($bn), 2009 - 2012
Table 64: Cost Comparison of Surgeries, the US, the UK and India ($), 2009
Table 65: Healthcare Infrastructure, China, 2009
Table 66: Hospitals, by Bed Distribution, China, 2009
Table 67: Healthcare Professionals, China, 2005
Table 68: Organizations in Healthcare System in China
Table 69: Rise in Personal Disposable Income, China ($), 2005 - 2013
Table 70: Foreign Joint Stock Insurance Companies, China, 2010
Table 71: Foreign Joint Venture Insurance Companies, China, 2010
Table 72: Major Foreign Players in Insurance Sector, China, 2010
Table 73: Medical Equipment Market, China ($bn), 2009 - 2016
Table 74: Healthcare Infrastructure, Brazil, 2008
Table 75: Healthcare Infrastructure, Public and Private Distribution, Brazil (%), 2008
Table 76: Rede D’Or Infrastructure, Brazil, 2010
Table 77: Sociedade Beneficente Israelita Brasileira Albert Einstein (SBIBAE) Current Infrastructure and Future Plans, Brazil, 2010
Table 78: Cosmetic Surgeries, Cost Comparison, the US and Brazil ($), 2009
Table 79: Population Age Structure, Brazil (%) ,1950 - 2050
Table 80: Healthcare Coverage Provider, Number of Plan Members and Revenue, Brazil ($bn), 2009
Table 81: Top Private Healthcare Coverage Providers, Number of Plan Members and Revenue, Brazil ($m), 2009

Figure 1: National Healthcare Expenditure, Public and Private, the US (%), 2008 16
Figure 2: National Healthcare Expenditure, the US (% of GDP), 2000-2009 17
Figure 3: National Healthcare Expenditure, by Category, the US (%), 2008 18
Figure 4: National Healthcare Expenditure, Public versus Private, the US (%), 2008 19
Figure 5: National Healthcare Expenditure, per Capita by Source of Funding, the US (%), 2008 20
Figure 6: National Healthcare Expenditure, by Payer, the US (%), 2008 21
Figure 7: Community Hospitals by Bed Distribution, the US (%), 2006-2008 23
Figure 8: Health Insurance Coverage, the US (% of Population), 2009 25
Figure 9: Types of Health Insurance Plans, Public Versus Private, the US, 2009 25
Figure 10: Health Insurance Coverage, Private, the US (% of Population), 2009 26
Figure 11: Health Insurance Coverage, Public, the US (% of Population), 2009 27
Figure 12: Health Insurance Coverage, Public and Private, the US (% of Population), 2007-2009 28
Figure 13: Healthcare Regulation, the US, 2009 29
Figure 14: Composition of the HHS Budget, the US (%), 2010-2011 30
Figure 15: Sources of Funding, Public and Private, the US (%), 2008 32
Figure 16: Key Medical Breakthroughs, Cleveland Clinic, the US, 1940-2009 34
Figure 17: Population Age Structure, the US (million), 2000-2020 35
Figure 18: Leading Causes of Death, by Therapeutic Area, the US (%), 2007 36
Figure 19: National Healthcare Expenditure, Japan (% of GDP), 2000-2007 39
Figure 20: National Healthcare Expenditure, by Category, Japan (%), 2006 40
Figure 21: National Healthcare Expenditure, Per Capita by Source of Funding, Japan (%), 2007 41
Figure 22: Hospitals, by Bed Distribution, Japan (%), 2007-2008 43
Figure 23: Health Insurance Coverage, Japan (million), 2008 46
Figure 24: Healthcare Regulation, Japan, 2009 47
Figure 25: Population Age Structure, Japan (million), 2000-2020 49
Figure 26: Leading Causes of Death, by Therapeutic Area, Japan (%), 2009 50
Figure 27: Leading Cause of Death, Rate Per 100,000 Population, Japan, 2000-2009 51
Figure 28: National Healthcare Expenditure, France (% of GDP), 2000-2008 53
Figure 29: National Healthcare Expenditure, by Category, France (%), 2008 54
Figure 30: National Healthcare Expenditure, Per Capita by Source of Funding, France (%), 2008 55
Figure 31: Healthcare Regulation, France, 2010 60
Figure 32: Population Age Structure, France (million), 2000-2020 62
Figure 33: Leading Causes of Death, by Therapeutic Area, France (%), 2005 63
Figure 34: National Health Expenditure, Italy (% of GDP), 2000-2009 66
Figure 35: National Health Expenditure, Per Capita by Source of Funding, Italy (%), 2008 67
Figure 36: Hospitals, Distribution by Type, Italy (%), 2005 68
Figure 37: Healthcare Regulation, Italy, 2010 70
Figure 38: Population Age Structure, Italy (million), 2000-2020 73
Figure 39: Leading Causes of Death, by Therapeutic Area, Italy (%), 2002 74
Figure 40: National Healthcare Expenditure, Germany (% of GDP), 2000-2008 77
Figure 41: National Healthcare Expenditure, by Category, Germany (%), 2008 78
Figure 42: National Healthcare Expenditure, Per Capita by Source of Funding, Germany (%), 2008 79
Figure 43: Healthcare Regulation, Germany, 2010 82
Figure 44: Population Age Structure, Germany (million), 2000-2020 84
Figure 45: Leading Causes of Death, by Therapeutic Area, Germany (%), 2005 85
Figure 46: National Healthcare Expenditure, Spain (% of GDP), 2000-2008 88
Figure 47: National Healthcare Expenditure, by Category, Spain (%), 2008 89
Figure 48: National Healthcare Expenditure, Per Capita by Source of Funding, Spain (%), 2008 90
Figure 49: Hospitals, by Bed Distribution, Spain, 2008 91
Figure 50: Healthcare Regulation, Spain, 2010 93
Figure 51: Population Age Structure, Spain (million), 2000-2020 95
Figure 52: Leading Causes of Death, by Therapeutic Area, Spain (%), 2007 96
Figure 53: Leading Causes of Death, by Age, Spain (%), 2007 97
Figure 54: National Health Expenditure, the UK (% of GDP), 2000-2008 99
Figure 55: Health Care Expenditure, Per Capita by Source of Funding, the UK (%), 2008 100
Figure 56: Healthcare Regulation, the UK, 2010 103
Figure 57: Milestones of RNOH, the UK, 1930-1980 104
Figure 58: Population Age Structure, the UK (million), 2000-2020 105
Figure 59: Leading Causes of Death, by Therapeutic Area, the UK (%), 2005 106
Figure 60: National Healthcare Expenditure, India, 2008 109
Figure 61: Healthcare Infrastructure, India, 2009 110
Figure 62: Healthcare Infrastructure, Public and Private Distribution, India (%), 2009 111
Figure 63: Public Healthcare Infrastructure, India 112
Figure 64: Hospitals Size, Private Sector, India (%), 2009 113
Figure 65: Evolution of Private Healthcare Sector, India 114
Figure 66: Benefits of Special Economic Zones, India 114
Figure 67: The Union Ministry of Health and Family Welfare Structure, India 115
Figure 68: Types of Institutions Accredited by National Accreditation Board for Hospitals & Healthcare Providers (NABH), India, 2010 117
Figure 69: Structure, Apollo Hospitals Enterprise Ltd, India, 2009 120
Figure 70: Fortis Healthcare, Important Deals, India 121
Figure 71: Patient Value Proposition, India 125
Figure 72: Population Age Structure, India (million), 2000 2020 127
Figure 73: Leading Causes of Death, by Therapeutic Area, India (%), 2007 128
Figure 74: Health Insurance Companies Landscape, India, 2010 130
Figure 75: Health Insurance Market by Public and Private Sector, India (%), 2010 130
Figure 76: Health Insurance Market Share by Companies, India (%), 2010 131
Figure 77: Insured inpatients, India (% of Population), 2010 132
Figure 78: Medical Tourism Revenue, India ($bn), 2009 2012 133
Figure 79: Medical Equipment Industry, India (%), 2009 135
Figure 80: National Healthcare Expenditure (% of GDP), China 2008 137
Figure 81: Hospital System, China, 2009 138
Figure 82: Hospitals, by Type, China (%), 2009 139
Figure 83: Hospitals, by Bed Distribution, China (%), 2009 140
Figure 84: Healthcare Professionals, China (%), 2005 141
Figure 85: Hospitals, Public and Private (%), China, 2009 142
Figure 86: Investment Plan, Healthcare Reforms, China (%), 2009 144
Figure 87: Healthcare Reform, China, 2009 144
Figure 88: Healthcare System, Administrative Structure of Government, China 147
Figure 89: Population Aged 65 and Above, China (% of Population), 2008 2040 153
Figure 90: Increase in Personal Disposable Income, China ($), 2005 2013 154
Figure 91: Healthcare Insurance Sector, Key Developments, China 155
Figure 92: Medical Equipment Market, China ($bn), 2009 2016 158
Figure 93: National Healthcare Expenditure, Brazil (% of GDP), 2008 161
Figure 94: Healthcare Infrastructure, Brazil, 2008 162
Figure 95: Healthcare Professionals, Brazil (%), 2008 163
Figure 96: Hospitals, by Bed Distribution, Brazil (%), 2008 163
Figure 97: Healthcare Infrastructure, Public and Private Distribution, Brazil (%), 2008 164
Figure 98: Hospitals Distribution, Public and Private Sector, Brazil (%), 2008 165
Figure 99: Key Events Rede DOr, Brazil 167
Figure 100: Sao Luiz Hospitals and Infrastructure, Brazil, 2010 168
Figure 101: Population Age Structure, Brazil (%), 1950 2050 172
Figure 102: Health Indicators, Brazil, 2009 173
Figure 103: Reimbursement in Brazil, 2009 174
Figure 104: Healthcare Coverage Provider, by Plan Members, Brazil (%), 2009 175
Figure 105: Healthcare Coverage Provider, by Revenue, Brazil (%), 2009 176
Figure 106: Healthcare Opportunities, Brazil, 2010 177
Figure 107: Healthcare Delivery Challenges, Brazil, 2010 179